Today, researchers and clinicians are under great pressure to develop therapies capable of reversing or significantly impacting the progression of disease. In recent years, the arrival of the cell and gene therapy industries have introduced the possibility of providing transformative, durable and potentially curative outcomes for a diverse range of life-threatening conditions, as well as injuries, degenerative diseases, genetic disorders, and cancers. [Read more…]
GenXovite: Pioneering an Open Source Platform for Revolutionary Regenerative Medicine Training
In an era marked by rapid medical advancements, GenXovite emerges as a beacon of innovation, poised to reshape the landscape of regenerative medicine education. With an unwavering commitment to empower physicians and healthcare professionals with the most sophisticated training, GenXovite’s mission is to forge a path toward effectiveness and productivity in this transformative field. [Read more…]
Stem Cell Treatments For Macular Degeneration
Macular degeneration is a crushing condition, leading to loss of visual acuity, and in some cases, eventual blindness. Even those who don’t experience total eyesight loss suffer a frustrating degradation of central vision, which makes driving, using the computer or other devices, recognizing faces, reading and many other activities nearly impossible to do. However, recent advancements in stem cell treatments for macular degeneration are providing a beacon of hope to many. [Read more…]
Gene & cell therapy manufacturing specialist Ascend launches with over $130M of funding as expert teams merge
LONDON, May 9, 2023 — Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy technologies, announces that it has launched as a facilitator for gene therapy companies to help translate product ideas into viable clinical programs.
Ascend offers process development, clinical manufacturing, and analytical and regulatory support for biotech companies working in advanced modalities requiring flexible CMC services. Originally founded by Monograph Capital, Ascend has raised a total of $132.5M, most recently completing a Series A fundraise led by Abingworth and Petrichor, supported by DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management, Digitalis Ventures and Ajinomoto Co., Inc. [Read more…]
Who Discovered Stem Cells? The Answers Revealed
Who discovered stem cells is a question worthy of exploration. While Robert Hooke first discovered the concept of cells themselves, the discovery of stem cells is usually credited to Drs. James Till & Ernset McCulloch.
For several hundred years, researchers have known that the human body is comprised of trillions of tiny structures. Known as cells, these structures can only be seen at a microscopic level. These cells come in hundreds of variations – 200, to be exact – and serve multitudinous functions within the human body. These functions include pumping blood, digesting food, and ridding our bodies of toxins and waste products, among others. [Read more…]
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 47
- Next Page »